Skip to content

AYURVEDIC TREATMENT FOR UTERINE FIBROID

A CLINICAL STUDY TO EVALUATE THE EFFECT OF MULAKA KSHARA IN THE MANAGEMENT OF UTERINE FIBROID.

Status
Recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/03/008129
Enrollment
30
Registered
2017-03-17
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients Diagnosed With Uterine Fibroid

Interventions

Intervention1: Mulaka Kshara: Dose-250mg Route of administration-oral Frequency-twice a day Intake-after meal with luke warm water Control Intervention1: Not applicable: Not applicable

Sponsors

Parul Ayurved Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age between 20 to 55 years Patients having single or multiple fibroid size Submucous fibroid The patients either asymptomatic or having clinical signs and symptoms of uterine fibroid.e.g menorrhagia, pressure pain, anaemia etc and confirmed by USG.

Exclusion criteria

Exclusion criteria: Pregnant woman with fibroid or women with Hb Ovarian tumour, malignant tumours along with fibroid. Patients with uncontrolled hypertension, tuberculosis, diabetes mellitus and any other systemic disease. Broad ligament fibroid Pedunculated fibroid

Design outcomes

Primary

MeasureTime frame
the size of the fibroid will be reduced within 3 months.Timepoint: the size of the fibroid will be reduced within 3 months.

Secondary

MeasureTime frame
main signs and symptoms of fibroid will be reduced within 3 monthsTimepoint: main signs and symptoms of fibroid will be reduced within 3 months

Countries

India

Contacts

Public ContactDHARITA PATEL

PARUL INSTITUTE OF AYURVED,VADODARA

hemant.toshikhane@paruluniversity.ac.in9964596478

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026